335 related articles for article (PubMed ID: 23633194)
1. The DPP-4 inhibitor linagliptin restores β-cell function and survival in human isolated islets through GLP-1 stabilization.
Shah P; Ardestani A; Dharmadhikari G; Laue S; Schumann DM; Kerr-Conte J; Pattou F; Klein T; Maedler K
J Clin Endocrinol Metab; 2013 Jul; 98(7):E1163-72. PubMed ID: 23633194
[TBL] [Abstract][Full Text] [Related]
2. Significance of vascular dipeptidyl peptidase-4 inhibition on vascular protection in Zucker diabetic fatty rats.
Takai S; Sakonjo H; Jin D
J Pharmacol Sci; 2014; 125(4):386-93. PubMed ID: 25030743
[TBL] [Abstract][Full Text] [Related]
3. Differential Effects of Linagliptin on the Function of Human Islets Isolated from Non-diabetic and Diabetic Donors.
Zhang Y; Wu M; Htun W; Dong EW; Mauvais-Jarvis F; Fonseca VA; Wu H
Sci Rep; 2017 Aug; 7(1):7964. PubMed ID: 28801559
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of dipeptidyl peptidase-4 (DPP-4) inhibitor against increased β cell apoptosis induced by dietary sucrose and linoleic acid in mice with diabetes.
Shirakawa J; Amo K; Ohminami H; Orime K; Togashi Y; Ito Y; Tajima K; Koganei M; Sasaki H; Takeda E; Terauchi Y
J Biol Chem; 2011 Jul; 286(29):25467-76. PubMed ID: 21613229
[TBL] [Abstract][Full Text] [Related]
5. Sitagliptin and Roux-en-Y gastric bypass modulate insulin secretion via regulation of intra-islet PYY.
Guida C; McCulloch LJ; Godazgar M; Stephen SD; Baker C; Basco D; Dong J; Chen D; Clark A; Ramracheya RD
Diabetes Obes Metab; 2018 Mar; 20(3):571-581. PubMed ID: 28892258
[TBL] [Abstract][Full Text] [Related]
6. Effects of DPP-4 inhibitors on the heart in a rat model of uremic cardiomyopathy.
Chaykovska L; von Websky K; Rahnenführer J; Alter M; Heiden S; Fuchs H; Runge F; Klein T; Hocher B
PLoS One; 2011; 6(11):e27861. PubMed ID: 22125632
[TBL] [Abstract][Full Text] [Related]
7. Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury.
Terawaki Y; Nomiyama T; Kawanami T; Hamaguchi Y; Takahashi H; Tanaka T; Murase K; Nagaishi R; Tanabe M; Yanase T
Cardiovasc Diabetol; 2014 Nov; 13():154. PubMed ID: 25407968
[TBL] [Abstract][Full Text] [Related]
8. The dipeptidyl peptidase-4 inhibitor linagliptin attenuates inflammation and accelerates epithelialization in wounds of diabetic ob/ob mice.
Schürmann C; Linke A; Engelmann-Pilger K; Steinmetz C; Mark M; Pfeilschifter J; Klein T; Frank S
J Pharmacol Exp Ther; 2012 Jul; 342(1):71-80. PubMed ID: 22493041
[TBL] [Abstract][Full Text] [Related]
9. Effects of combining linagliptin treatment with BI-38335, a novel SGLT2 inhibitor, on pancreatic islet function and inflammation in db/db mice.
Chen L; Klein T; Leung PS
Curr Mol Med; 2012 Sep; 12(8):995-1004. PubMed ID: 22804249
[TBL] [Abstract][Full Text] [Related]
10. Linagliptin enhances neural stem cell proliferation after stroke in type 2 diabetic mice.
Darsalia V; Olverling A; Larsson M; Mansouri S; Nathanson D; Nyström T; Klein T; Sjöholm Å; Patrone C
Regul Pept; 2014 May; 190-191():25-31. PubMed ID: 24821550
[TBL] [Abstract][Full Text] [Related]
11. Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice.
Waget A; Cabou C; Masseboeuf M; Cattan P; Armanet M; Karaca M; Castel J; Garret C; Payros G; Maida A; Sulpice T; Holst JJ; Drucker DJ; Magnan C; Burcelin R
Endocrinology; 2011 Aug; 152(8):3018-29. PubMed ID: 21673098
[TBL] [Abstract][Full Text] [Related]
12. Lack of preservation of insulin gene expression by a glucagon-like peptide 1 agonist or a dipeptidyl peptidase 4 inhibitor in an in vivo model of glucolipotoxicity.
Fontés G; Hagman DK; Latour MG; Semache M; Poitout V
Diabetes Res Clin Pract; 2010 Mar; 87(3):322-8. PubMed ID: 20092903
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of dipeptidyl peptidase 4 by BI-1356, a new drug for the treatment of beta-cell failure in type 2 diabetes.
Rungby J
Expert Opin Investig Drugs; 2009 Jun; 18(6):835-8. PubMed ID: 19426127
[TBL] [Abstract][Full Text] [Related]
14. Dipeptidyl peptidase IV inhibition activates CREB and improves islet vascularization through VEGF-A/VEGFR-2 signaling pathway.
Samikannu B; Chen C; Lingwal N; Padmasekar M; Engel FB; Linn T
PLoS One; 2013; 8(12):e82639. PubMed ID: 24349326
[TBL] [Abstract][Full Text] [Related]
15. Sitagliptin: profile of a novel DPP-4 inhibitor for the treatment of type 2 diabetes (update).
Gallwitz B
Drugs Today (Barc); 2007 Nov; 43(11):801-14. PubMed ID: 18174966
[TBL] [Abstract][Full Text] [Related]
16. Native, Intact Glucagon-Like Peptide 1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions.
Sternkopf M; Nagy M; Baaten CCFMJ; Kuijpers MJE; Tullemans BME; Wirth J; Theelen W; Mastenbroek TG; Lehrke M; Winnerling B; Baerts L; Marx N; De Meester I; Döring Y; Cosemans JMEM; Daiber A; Steven S; Jankowski J; Heemskerk JWM; Noels H
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):e65-e77. PubMed ID: 31893947
[TBL] [Abstract][Full Text] [Related]
17. Neprilysin inhibition in mouse islets enhances insulin secretion in a GLP-1 receptor dependent manner.
Esser N; Barrow BM; Choung E; Shen NJ; Zraika S
Islets; 2018; 10(5):175-180. PubMed ID: 30142012
[TBL] [Abstract][Full Text] [Related]
18. DPP IV inhibitor suppresses STZ-induced islets injury dependent on activation of the IGFR/Akt/mTOR signaling pathways by GLP-1 in monkeys.
Zhang Y; Chen Y; Cheng J; Guo Z; Lu Y; Tian B
Biochem Biophys Res Commun; 2015 Jan; 456(1):139-44. PubMed ID: 25446112
[TBL] [Abstract][Full Text] [Related]
19. The DPP4 inhibitor linagliptin delays the onset of diabetes and preserves β-cell mass in non-obese diabetic mice.
Jelsing J; Vrang N; van Witteloostuijn SB; Mark M; Klein T
J Endocrinol; 2012 Sep; 214(3):381-7. PubMed ID: 22761275
[TBL] [Abstract][Full Text] [Related]
20. Gliptin and GLP-1 analog treatment improves survival and vascular inflammation/dysfunction in animals with lipopolysaccharide-induced endotoxemia.
Steven S; Hausding M; Kröller-Schön S; Mader M; Mikhed Y; Stamm P; Zinßius E; Pfeffer A; Welschof P; Agdauletova S; Sudowe S; Li H; Oelze M; Schulz E; Klein T; Münzel T; Daiber A
Basic Res Cardiol; 2015 Mar; 110(2):6. PubMed ID: 25600227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
